What is it about?
Detection of antinuclear antibodies (ANA) by indirect immunofluorescence assay using HEp-2 cells (HEp-2 IFA) is used to screen for various autoimmune diseases. We report on a questionnaire that was developed to collect information on Hep-2 IFA methodology, computer-assisted diagnosis systems, training, inter-observer variability, quality assessment, reagent lot change control, and method verification.
Featured Image
Read the Original
This page is a summary of: Analytical aspects of the antinuclear antibody test by HEp-2 indirect immunofluorescence: EFLM report on an international survey, Clinical Chemistry and Laboratory Medicine (CCLM), March 2023, De Gruyter,
DOI: 10.1515/cclm-2023-0210.
You can read the full text:
Contributors
Be the first to contribute to this page







